Transforming Trial Participation in GI Cancers

What are we doing to increase clinical trial participation? What could we be doing?

Each of our organizations works in our own way to improve clinical trial participation. But what would it be like if we joined our efforts together to make a real difference in GI cancer trials participation today and in the years to come?  How much more impact could we have?

The Alliance has already committed to developing a high impact program to improve clinical trial participation.  Before we begin planning, and seeking funding for this effort, we need to make sure that

• We have a shared understanding about the greatest challenges to clinical trial participation
• We develop a strategy that can excite and motivate us, and can have the greatest impact on increasing trial participation

We hope you will join us for an interactive, thought-provoking and intriguing 5 part webinar series especially designed for us and our work.

Most of us already know a lot about clinical trials. But before we develop our strategic initiative to improve clinical trial participation for GI Cancers in 2019, we need a greater collective understanding of several topics, including

1. 10 facts about clinical trials even you may not have thought about
2. What does social justice, economics and science have to do with trial accrual for GI cancers?
3. “But we’ve always done it that way:” 5 common approaches that actually discourage patient participation in trials
4. Why would I want to do that? Actual differences between receiving standard treatment and treatment within a clinical trial, from the patient perspective
5. What makes it so hard to increase patient participation in trials: 3 different perspectives
   1. Oncologists and institutions: Behaviors, policies and procedures
   2. Industry: trial design
   3. Patients seeking treatment: Awareness, Opportunity, Acceptance
6. Pushing the “lever:” Where are the “sweet spots” for realistic improvement around GI cancers trial accrual
   1. Advocate engagement in patient centered trial design
   2. Changes in institutional procedures and policies
   3. Getting at the “narrow window” of opportunity between diagnosis and treatment
7. Setting course for Alliance’s new strategic initiative to improve clinical trial participation

If you missed the other parts of this webinar series, you can watch them below:

• Part 1 – 10 facts about clinical trials even you may not have thought about
• Part 2 – What makes it so hard to increase patient participation in trials
• Part 3 – 10 common approaches to increase accrual that actually discourage patient participation
• Part 4 – Where are the “sweet spots” for realistic improvement around GI cancers trial accrual
• Part 5 – Webinar: Setting course for the Alliance’s new strategic initiative to improve clinical trial participation